NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 21 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,834,594 | -2.2% | 29,100,000 | -1.7% | 0.01% | -7.7% |
| Q2 2023 | $27,441,894 | 0.0% | 29,600,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $27,441,894 | +15.2% | 29,600,000 | +4.6% | 0.01% | +8.3% |
| Q4 2022 | $23,814,761 | -99.9% | 28,300,000 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $24,289,692,000 | -0.3% | 28,300,000 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $24,359,367,000 | -27.2% | 28,300,000 | 0.0% | 0.01% | -23.1% |
| Q4 2021 | $33,460,505,000 | -9.9% | 28,300,000 | +11.9% | 0.01% | -13.3% |
| Q3 2021 | $37,121,172,000 | +17.2% | 25,300,000 | +13.5% | 0.02% | +7.1% |
| Q2 2021 | $31,680,495,000 | +6.1% | 22,300,000 | +12.6% | 0.01% | +7.7% |
| Q1 2021 | $29,854,044,000 | -6.7% | 19,800,000 | 0.0% | 0.01% | -13.3% |
| Q4 2020 | $32,006,700,000 | +27.7% | 19,800,000 | -1.7% | 0.02% | +15.4% |
| Q3 2020 | $25,070,429,000 | +5.6% | 20,150,000 | -8.4% | 0.01% | -7.1% |
| Q2 2020 | $23,736,021,000 | – | 22,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 28,000,000 | $26,250,000 | 0.83% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 28,270,000 | $26,656,130 | 0.57% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,499,000 | $23,905,313 | 0.56% |
| LINDEN ADVISORS LP | 37,749,000 | $34,974,463 | 0.36% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,500,000 | $5,994,495 | 0.13% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 19,019,000 | $17,830,313 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 22,258,000 | $20,866 | 0.03% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 29,100,000 | $26,834,594 | 0.01% |
| NEW YORK STATE COMMON RETIREMENT FUND | 3,799,000 | $3,524 | 0.01% |
| JPMORGAN CHASE & CO | 395,000 | $367,638 | 0.00% |